Frauke Bellos

778 total citations
21 papers, 428 citations indexed

About

Frauke Bellos is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Frauke Bellos has authored 21 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Frauke Bellos's work include Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Frauke Bellos is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Frauke Bellos collaborates with scholars based in Germany, Austria and Greece. Frauke Bellos's co-authors include Wolfgang Kern, Susanne Schnittger, Torsten Haferlach, Claudia Haferlach, Alexander Kohlmann, Sandra Weißmann, Anthony D. Ho, Ulrich Mahlknecht, Vera Grossmann and Sonja Schindela and has published in prestigious journals such as Blood, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Frauke Bellos

19 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frauke Bellos Germany 11 254 145 138 98 71 21 428
Cristina N. Alonso Argentina 11 165 0.6× 194 1.3× 91 0.7× 74 0.8× 27 0.4× 30 384
N J Chao United States 13 327 1.3× 95 0.7× 70 0.5× 168 1.7× 26 0.4× 18 491
Mikiya Endo Japan 11 134 0.5× 67 0.5× 114 0.8× 47 0.5× 24 0.3× 27 350
Qi Gao United States 9 180 0.7× 51 0.4× 118 0.9× 126 1.3× 30 0.4× 30 308
D Leboeuf France 7 242 1.0× 133 0.9× 149 1.1× 80 0.8× 14 0.2× 8 424
Bérengère Gruson France 10 166 0.7× 65 0.4× 56 0.4× 51 0.5× 23 0.3× 21 328
JP Greer United States 6 151 0.6× 46 0.3× 87 0.6× 265 2.7× 39 0.5× 8 452
Noa Tal Israel 6 164 0.6× 202 1.4× 63 0.5× 100 1.0× 13 0.2× 11 356
H. T. Kim United States 7 134 0.5× 46 0.3× 77 0.6× 93 0.9× 31 0.4× 7 358
E R van Wering Netherlands 11 284 1.1× 246 1.7× 144 1.0× 68 0.7× 9 0.1× 14 467

Countries citing papers authored by Frauke Bellos

Since Specialization
Citations

This map shows the geographic impact of Frauke Bellos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frauke Bellos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frauke Bellos more than expected).

Fields of papers citing papers by Frauke Bellos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frauke Bellos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frauke Bellos. The network helps show where Frauke Bellos may publish in the future.

Co-authorship network of co-authors of Frauke Bellos

This figure shows the co-authorship network connecting the top 25 collaborators of Frauke Bellos. A scholar is included among the top collaborators of Frauke Bellos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frauke Bellos. Frauke Bellos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner‐Ballon, Orianne, Peter Bettelheim, Frauke Bellos, et al.. (2021). ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry. Cytometry Part B Clinical Cytometry. 104(1). 66–76. 11 indexed citations
2.
3.
Hoermann, Gregor, Niroshan Nadarajah, Constance Baer, et al.. (2021). Incidential Findings of Mutations in the PIGA Gene Are Highly Specific for the Presence of PNH Clones. Blood. 138(Supplement 1). 1117–1117.
4.
Wagner‐Ballon, Orianne, Peter Bettelheim, Frauke Bellos, et al.. (2021). ELN IMDS Flow Working Group Validation of the Monocyte Assay for Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry. Blood. 138(Supplement 1). 2602–2602. 2 indexed citations
5.
6.
Zenger, Melanie, Susanne Schnittger, Sandra Weißmann, et al.. (2014). Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%. Genes Chromosomes and Cancer. 53(6). 524–536. 57 indexed citations
7.
Grossmann, Vera, Claudia Haferlach, Sandra Weißmann, et al.. (2013). The molecular profile of adult T‐cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T‐ALL. Genes Chromosomes and Cancer. 52(4). 410–422. 114 indexed citations
8.
Zenger, Melanie, Susanne Schnittger, Sandra Weißmann, et al.. (2013). Acute Lymphoblastic Leukemia (ALL) With Low-Hypodiploid/Near-Triploid Karyotype Is a Specific Clinical Entity Characterized By a High TP53 Mutation Frequency. Blood. 122(21). 615–615. 2 indexed citations
9.
10.
Middeke, Jan Moritz, Dietrich W. Beelen, Michael Stadler, et al.. (2012). Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−. Blood. 120(12). 2521–2528. 42 indexed citations
11.
Bellos, Frauke, Tamara Alpermann, Claudia Haferlach, et al.. (2012). Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients. Cytometry Part B Clinical Cytometry. 82B(5). 295–304. 10 indexed citations
12.
Radujkovic, Aleksandar, Frauke Bellos, Mindaugas Andrulis, Anthony D. Ho, & Michael Hundemer. (2011). Charcot‐Leyden crystals and bone marrow necrosis in acute myeloid leukemia. European Journal Of Haematology. 86(5). 451–452. 4 indexed citations
13.
Ran, Dan, Mario Schubert, Volker Eckstein, et al.. (2011). Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance. Experimental Hematology. 40(2). 155–165.e1. 30 indexed citations
14.
Dietrich, Sascha, Mindaugas Andrulis, Ute Hegenbart, et al.. (2011). Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity. Biology of Blood and Marrow Transplantation. 17(8). 1250–1254. 68 indexed citations
15.
Berger, Anne, et al.. (2009). Symptomatic Hyponatraemia Caused by Cylophosphamide. Onkologie. 32(5). 1–1. 5 indexed citations
16.
Bellos, Frauke & Ulrich Mahlknecht. (2008). Valproic Acid and All-Trans Retinoic Acid: Meta-Analysis of a Palliative Treatment Regimen in AML and MDS Patients. Oncology Research and Treatment. 31(11). 629–633. 28 indexed citations
17.
Cremer, Friedrich W., Mutlu Kartal‐Kaess, Dirk Hose, et al.. (2005). High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH. Cancer Genetics and Cytogenetics. 161(2). 116–124. 19 indexed citations
18.
Kasper, Bernd, Julia Meißner, Frauke Bellos, et al.. (2004). Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?. Supportive Care in Cancer. 12(3). 205–207. 19 indexed citations
19.
Bellos, Frauke, Hartmut Goldschmidt, Marcus Dorner, Anthony D. Ho, & M Moos. (1999). Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNA. Annals of Oncology. 10(3). 323–328. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina N. Alonso Breakdown of academic impact, for papers by N J Chao Breakdown of academic impact, for papers by Mikiya Endo Breakdown of academic impact, for papers by Qi Gao Breakdown of academic impact, for papers by D Leboeuf Breakdown of academic impact, for papers by Bérengère Gruson Breakdown of academic impact, for papers by JP Greer Breakdown of academic impact, for papers by Noa Tal Breakdown of academic impact, for papers by H. T. Kim Breakdown of academic impact, for papers by E R van Wering
Rankless by CCL
2026